Committee Opinion No. 704: Human Papillomavirus Vaccination

被引:19
作者
Eckert, Linda O'Neal
Moscicki, Anna-Barbara
机构
关键词
HPV VACCINE; ADVISORY-COMMITTEE; CLINICAL-TRIALS; UNITED-STATES; YOUNG-WOMEN; IMMUNOGENICITY; RECOMMENDATIONS; ADOLESCENTS; OUTCOMES; IMPACT;
D O I
10.1097/AOG.0000000000002052
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human papillomavirus (HPV) is associated with anogenital cancer (including cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts. The HPV vaccination significantly reduces the incidence of anogenital cancer and genital warts. Despite the benefits of HPV vaccines, only 41.9% of girls in the recommended age group, and only 28.1% of males in the recommended age group have received all recommended doses. Compared with many other countries, HPV vaccination rates in the United States are unacceptably low. The U.S. Food and Drug Administration has approved three vaccines that are effective at preventing HPV infection. These vaccines cover 2, 4, or 9 HPV serotypes, respectively. Safety data for all three HPV vaccines are reassuring. The HPV vaccines are recommended for girls and boys aged 11-12 years and can be given to females and males up to age 26 years. The Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend routine HPV vaccination for girls and boys at the target age of 11-12 years (but it may be given from the age of 9 years) as part of the adolescent immunization platform in order to help reduce the incidence of anogenital cancer and genital warts associated with HPV infection. Obstetrician-gynecologists and other health care providers should stress to parents and patients the benefits and safety of HPV vaccination and offer HPV vaccines in their offices.
引用
收藏
页码:E173 / E178
页数:6
相关论文
共 28 条
[1]   Sexual Activity-Related Outcomes After Human Papillomavirus Vaccination of 11- to 12-Year-Olds [J].
Bednarczyk, Robert A. ;
Davis, Robert ;
Ault, Kevin ;
Orenstein, Walter ;
Omer, Saad B. .
PEDIATRICS, 2012, 130 (05) :798-805
[2]   Cross-roads in the classification of papillomaviruses [J].
de Villiers, Ethel-Michele .
VIROLOGY, 2013, 445 (1-2) :2-10
[3]   Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women A Randomized Clinical Trial [J].
Dobson, Simon R. M. ;
McNeil, Shelly ;
Dionne, Marc ;
Dawar, Meena ;
Ogilvie, Gina ;
Krajden, Mel ;
Sauvageau, Chantal ;
Scheifele, David W. ;
Kollmann, Tobias R. ;
Halperin, Scott A. ;
Langley, Joanne M. ;
Bettinger, Julie A. ;
Singer, Joel ;
Money, Deborah ;
Miller, Dianne ;
Naus, Monika ;
Marra, Fawziah ;
Young, Eric .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (17) :1793-1802
[4]   Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine [J].
Garland, Suzanne M. ;
Cheung, Tak-Hong ;
McNeill, Shelly ;
Petersen, Lone Kjeld ;
Romaguera, Josefina ;
Vazquez-Narvaez, Jorge ;
Bautista, Oliver ;
Shields, Christine ;
Vuocolo, Scott ;
Luxembourg, Alain .
VACCINE, 2015, 33 (48) :6855-6864
[5]   Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine A Combined Analysis of Five Randomized Controlled Trials [J].
Garland, Suzanne M. ;
Ault, Kevin A. ;
Gall, Stanley A. ;
Paavonen, Jorma ;
Sings, Heather L. ;
Ciprero, Karen L. ;
Saah, Alfred ;
Marino, Deborah ;
Ryan, Desmond ;
Radley, David ;
Zhou, Haiping ;
Haupt, Richard M. ;
Garner, Elizabeth I. O. .
OBSTETRICS AND GYNECOLOGY, 2009, 114 (06) :1179-1188
[6]   HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and Women [J].
Gillison, Maura L. ;
Chaturvedi, Anil K. ;
Lowy, Douglas R. .
CANCER, 2008, 113 (10) :3036-3046
[7]  
Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1184
[8]   HPV Type Attribution in High-Grade Cervical Lesions: Assessing the Potential Benefits of Vaccines in a Population-Based Evaluation in the United States [J].
Hariri, Susan ;
Unger, Elizabeth R. ;
Schafer, Sean ;
Niccolai, Linda M. ;
Park, Ina U. ;
Bloch, Karen C. ;
Bennett, Nancy M. ;
Steinau, Martin ;
Johnson, Michelle L. ;
Markowitz, Lauri E. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (02) :393-399
[9]   HIV-Related Risk Behaviors Among Male High School Students Who Had Sexual Contact with Males-17 Large Urban School Districts, United States, 2009-2013 [J].
Kann, Laura ;
Olsen, Emily O'Malley ;
Kinchen, Steve ;
Morris, Elana ;
Wolitski, Richard J. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (05) :106-109
[10]   Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study [J].
Leval, Amy ;
Herweijer, Eva ;
Ploner, Alexander ;
Eloranta, Sandra ;
Simard, Julia Fridman ;
Dillner, Joakim ;
Young, Cecilia ;
Netterlid, Eva ;
Sparen, Par ;
Arnheim-Dahlstrom, Lisen .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07) :469-474